TP53 and ovarian cancer: We performed KEGG and GO enrichment analysis on 29 differentially expressed PRGs in ovarian cancer, with q-value≤0.05 as the threshold, and found that these genes were mainly enriched in apoptosis, NOD-like receptor signaling pathway, platinum drug resistance, and p53 signaling pathway.